These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11757787)

  • 1. Helivax Antex Biologics.
    Giudice GD
    Curr Opin Investig Drugs; 2001 Jul; 2(7):896-9. PubMed ID: 11757787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
    Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
    Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
    Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
    Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
    Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
    Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
    Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
    Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine against Helicobacter pylori: fact or fiction?
    Michetti P
    Gut; 1997 Dec; 41(6):728-30. PubMed ID: 9462202
    [No Abstract]   [Full Text] [Related]  

  • 8. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
    Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
    Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori.
    Ikuse T; Blanchard TG; Czinn SJ
    Curr Top Microbiol Immunol; 2019; 421():1-19. PubMed ID: 31123883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
    Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
    Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
    Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
    Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
    World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
    Marchetti M; Rossi M; Giannelli V; Giuliani MM; Pizza M; Censini S; Covacci A; Massari P; Pagliaccia C; Manetti R; Telford JL; Douce G; Dougan G; Rappuoli R; Ghiara P
    Vaccine; 1998 Jan; 16(1):33-7. PubMed ID: 9607006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
    Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Peng X; Zhang R; Wang C; Yu F; Yu M; Chen S; Fan Q; Xi Y; Duan G
    Cells; 2019 Aug; 8(9):. PubMed ID: 31461854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against natural Helicobacter pylori infection in nonhuman primates.
    Dubois A; Lee CK; Fiala N; Kleanthous H; Mehlman PT; Monath T
    Infect Immun; 1998 Sep; 66(9):4340-6. PubMed ID: 9712786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.